Nasus Pharma NSRX Ratios (2024-2026)

NYSE NSRX
$3.61 +0.02 (+0.42%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Nasus Pharma Quarterly Ratios

Periods 4 quarters
Latest Jun 2026

Nasus Pharma ratios data for the quarter ended Jun 2026. These financial ratios cover 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Jun2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 0.68M2.82M8.73M
Equity AverageEquity Avg. -3.76M-0.77M6.88M
Invested CapitalInvested Cap. -1.41M-1.75M2.77M
Leverage & Solvency
Debt Ratio 2.514.01
Valuation
Price to BookP/B 29.802.87
Enterprise Value 78.20M19.74M
Market Capitalization 82.49M31.55M

Nasus Pharma Ratios API

Pull Nasus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NSRX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY